Raleigh startup targets severe allergic reactions (anaphylaxis) with dry powder

Scott Lyman believes his small biopharmaceutical startup company in Raleigh has devised a more patient-friendly, rapid-acting and cost-effective way to ensure patients have access to epinephrine during emergencies.

Read More